Baxion
Screening
Tags
Alerts
Theme
Kyntra Bio, Inc.
KYNB
·
NASDAQ
·
$6.85
Share Price as of 11/2
·
$28M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/16/26
10-Q
Q3 ended 09/30/25
11/10/25
10-Q
Q2 ended 06/30/25
08/11/25
Disclosures
Filter
8-K
Current report
10/06/26
8-K
Current report
10/01/26
8-K
Current report
08/31/26
8-K
Current report
08/13/26
8-K
Current report
06/16/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
02/24/25
S-8
Registration of securities for employees
08/07/24
S-3
Shelf registration
06/28/24
S-8
Registration of securities for employees
08/07/23
424B5
Prospectus supplement
02/27/23
Proxies
Filter
DEF 14A
Definitive proxy
04/27/26
DEFA14A
Additional proxy materials
04/27/26
DEF 14A
Definitive proxy
04/25/25
DEFA14A
Additional proxy materials
04/25/25
PRE 14A
Preliminary proxy
04/17/25
Ownership
Filter
Form 3
Initial insider ownership
10/06/26
Form 4
Insider transaction
10/06/26
Form 4
Insider transaction
09/09/26
Form 4
Insider transaction
09/09/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
ARS
Annual report to shareholders
04/27/26
ARS
Annual report to shareholders
04/25/25
EFFECT
Request for effectiveness
07/10/24
CORRESP
Correspondence with the SEC
07/09/24
UPLOAD
Letter from the SEC
07/09/24
Latest Filings
Filter
8-K
Current report
10/06/26
8-K
Current report
10/01/26
8-K
Current report
08/31/26
10-Q
Q2 ended 06/30/26
08/13/26
8-K
Current report
08/13/26
Ownership
Filter
Form 3
Initial insider ownership
10/06/26
Form 4
Insider transaction
10/06/26
Form 4
Insider transaction
09/09/26
Form 4
Insider transaction
09/09/26
SC 13G/A
Beneficial ownership (amended)
08/14/26